Passero, Lauren E http://orcid.org/0000-0001-8394-3917
Roberts, Megan C http://orcid.org/0000-0003-3434-2773
Funding for this research was provided by:
NCI and UNC-CH (an IBM Junior Faculty Development Award from the University of North Carolina at Chapel Hill and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR002490)
Article History
Received: 1 November 2023
Accepted: 9 March 2024
First Online: 28 March 2024
Declarations
:
: The qualitative study reported in this paper was granted an exemption from human subjects review by the Office of Human Research Ethics at the University of North Carolina at Chapel Hill (Study Number 21–0643).
: All participants provided verbal informed consent prior to study enrollment. All procedures followed were in accordance with US Federal Policy for the Protection of Human Subjects.
: Lauren Passero is a predoctoral fellow funded by Bristol Myers Squibb. Dr. Megan Roberts’ spouse hold stock in Merck and Thermo Fisher Scientific. The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.
: No non-human animal studies were carried out by the authors for this article.